author-photo

Kei Takamura

Hokkaido University

58

Papers

468

Citations

Citation Trend

Filter By

Papers (40) Sort By

Journal Conference Others

Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902).

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (2)
A Case of Hb Aalborg (HBB: c.223G>C) with Chronic Obstructive Pulmonary Disease: A First Familial Presentation in Japan.

2021 Hemoglobin
Show All
- Source
- Cite
- Save
Citations (0)
Nontraumatic Hemopneumothorax Treated by Transcatheter Arterial Embolization: : A Case Report From Japan

2020 Journal of The Japanese Association of Rural Medicine
Show All
- Source
- Cite
- Save
Citations (0)
A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703).

2020 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
A Case of Severe Respiratory Failure in a Patient with Sepsis From a Pressure Ulcer in Which Cooperation Among Many Professions Was Useful for Discharge From the Intensive Care Unit

2020 Journal of The Japanese Association of Rural Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival.

2020 Heliyon
Show All
- Source
- Cite
- Save
Citations (2)
Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302.

2020 International Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (114)
1572PA prospective phase II trial of carboplatin (CBDCA) and nab-paclitaxel (nabPTX) for advanced non-small cell lung cancer (NSCLC) with interstitial lung disease (ILD)

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)